These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 21690486)
1. Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. Belin de Chantemèle EJ; Mintz JD; Rainey WE; Stepp DW Hypertension; 2011 Aug; 58(2):271-9. PubMed ID: 21690486 [TBL] [Abstract][Full Text] [Related]
2. Deletion of protein tyrosine phosphatase 1b in proopiomelanocortin neurons reduces neurogenic control of blood pressure and protects mice from leptin- and sympatho-mediated hypertension. Bruder-Nascimento T; Butler BR; Herren DJ; Brands MW; Bence KK; Belin de Chantemèle EJ Pharmacol Res; 2015 Dec; 102():235-44. PubMed ID: 26523876 [TBL] [Abstract][Full Text] [Related]
3. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Prior LJ; Eikelis N; Armitage JA; Davern PJ; Burke SL; Montani JP; Barzel B; Head GA Hypertension; 2010 Apr; 55(4):862-8. PubMed ID: 20194306 [TBL] [Abstract][Full Text] [Related]
4. Exposure to a high-fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Prior LJ; Davern PJ; Burke SL; Lim K; Armitage JA; Head GA Hypertension; 2014 Feb; 63(2):338-45. PubMed ID: 24191287 [TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function. Belin de Chantemèle EJ; Muta K; Mintz J; Tremblay ML; Marrero MB; Fulton DJ; Stepp DW Circulation; 2009 Sep; 120(9):753-63. PubMed ID: 19687357 [TBL] [Abstract][Full Text] [Related]
6. Experimental hyperleptinemia in neonatal rats leads to selective leptin responsiveness, hypertension, and altered myocardial function. Samuelsson AM; Clark J; Rudyk O; Shattock MJ; Bae SE; South T; Pombo J; Redington K; Uppal E; Coen CW; Poston L; Taylor PD Hypertension; 2013 Sep; 62(3):627-33. PubMed ID: 23836797 [TBL] [Abstract][Full Text] [Related]
7. Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits. Barzel B; Lim K; Davern PJ; Burke SL; Armitage JA; Head GA J Hypertens; 2016 Mar; 34(3):464-73; discussion 473. PubMed ID: 26820476 [TBL] [Abstract][Full Text] [Related]
8. Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity. Belin de Chantemèle EJ; Ali MI; Mintz JD; Rainey WE; Tremblay ML; Fulton DJ; Stepp DW Hypertension; 2012 Nov; 60(5):1273-9. PubMed ID: 23045458 [TBL] [Abstract][Full Text] [Related]
9. Origin of Aberrant Blood Pressure and Sympathetic Regulation in Diet-Induced Obesity. Lim K; Barzel B; Burke SL; Armitage JA; Head GA Hypertension; 2016 Aug; 68(2):491-500. PubMed ID: 27296999 [TBL] [Abstract][Full Text] [Related]
10. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Kalil GZ; Haynes WG Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570 [TBL] [Abstract][Full Text] [Related]
11. Obesity-induced hypertension develops in young rats independently of the renin-angiotensin-aldosterone system. Smith AD; Brands MW; Wang MH; Dorrance AM Exp Biol Med (Maywood); 2006 Mar; 231(3):282-7. PubMed ID: 16514174 [TBL] [Abstract][Full Text] [Related]
12. Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice. Atawia RT; Faulkner JL; Mehta V; Austin A; Jordan CR; Kennard S; Belin de Chantemèle EJ Vascul Pharmacol; 2022 Oct; 146():107093. PubMed ID: 35914636 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms mediating renal sympathetic activation to leptin in obesity. Morgan DA; Thedens DR; Weiss R; Rahmouni K Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1730-6. PubMed ID: 18815209 [TBL] [Abstract][Full Text] [Related]
14. High aminopeptidase A activity contributes to blood pressure control in Morais RL; Hilzendeger AM; Visniauskas B; Todiras M; Alenina N; Mori MA; Araújo RC; Nakaie CR; Chagas JR; Carmona AK; Bader M; Pesquero JB Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H437-H445. PubMed ID: 27940965 [TBL] [Abstract][Full Text] [Related]
15. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285 [TBL] [Abstract][Full Text] [Related]
16. Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity. Packer M Circulation; 2018 Apr; 137(15):1614-1631. PubMed ID: 29632154 [TBL] [Abstract][Full Text] [Related]
17. Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice. Huby AC; Otvos L; Belin de Chantemèle EJ Hypertension; 2016 May; 67(5):1020-8. PubMed ID: 26953321 [TBL] [Abstract][Full Text] [Related]
18. Leptin Mediates High-Fat Diet Sensitization of Angiotensin II-Elicited Hypertension by Upregulating the Brain Renin-Angiotensin System and Inflammation. Xue B; Yu Y; Zhang Z; Guo F; Beltz TG; Thunhorst RL; Felder RB; Johnson AK Hypertension; 2016 May; 67(5):970-6. PubMed ID: 27021010 [TBL] [Abstract][Full Text] [Related]
19. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. Mark AL; Correia ML; Rahmouni K; Haynes WG J Hypertens; 2002 Jul; 20(7):1245-50. PubMed ID: 12131511 [TBL] [Abstract][Full Text] [Related]
20. Leptin and hypertension in obesity. Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]